BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tandler N, Mosch B, Pietzsch J. Protein and non-protein biomarkers in melanoma: a critical update. Amino Acids 2012;43:2203-30. [DOI: 10.1007/s00726-012-1409-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Gao F, Sihver W, Bergmann R, Belter B, Bolzati C, Salvarese N, Steinbach J, Pietzsch J, Pietzsch HJ. Synthesis, Characterization, and Initial Biological Evaluation of [99m Tc]Tc-Tricarbonyl-labeled DPA-α-MSH Peptide Derivatives for Potential Melanoma Imaging. ChemMedChem 2018;13:1146-58. [PMID: 29659163 DOI: 10.1002/cmdc.201800110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Heizmann CW. Ca2+-Binding Proteins of the EF-Hand Superfamily: Diagnostic and Prognostic Biomarkers and Novel Therapeutic Targets. Methods Mol Biol 2019;1929:157-86. [PMID: 30710273 DOI: 10.1007/978-1-4939-9030-6_11] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
3 Salgado MTSF, Fernandes E Silva E, Matsumoto AM, Mattozo FH, Amarante MCA, Kalil SJ, Votto APS. C-phycocyanin decreases proliferation and migration of melanoma cells: In silico and in vitro evidences. Bioorg Chem 2022;122:105757. [PMID: 35339928 DOI: 10.1016/j.bioorg.2022.105757] [Reference Citation Analysis]
4 Olaoba OT, Kadasah S, Vetter SW, Leclerc E. RAGE Signaling in Melanoma Tumors. Int J Mol Sci 2020;21:E8989. [PMID: 33256110 DOI: 10.3390/ijms21238989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Heizmann CW. S100 proteins: Diagnostic and prognostic biomarkers in laboratory medicine. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2019;1866:1197-206. [DOI: 10.1016/j.bbamcr.2018.10.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
6 Janka EA, Várvölgyi T, Sipos Z, Soós A, Hegyi P, Kiss S, Dembrovszky F, Csupor D, Kéringer P, Pécsi D, Solymár M, Emri G. Predictive Performance of Serum S100B Versus LDH in Melanoma Patients: A Systematic Review and Meta-Analysis. Front Oncol 2021;11:772165. [PMID: 34950582 DOI: 10.3389/fonc.2021.772165] [Reference Citation Analysis]
7 Herwig N, Belter B, Wolf S, Haase-Kohn C, Pietzsch J. Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells. J Cell Mol Med 2016;20:825-35. [PMID: 26928771 DOI: 10.1111/jcmm.12808] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
8 Neuber C, Belter B, Meister S, Hofheinz F, Bergmann R, Pietzsch HJ, Pietzsch J. Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments. Molecules 2018;23:E444. [PMID: 29462967 DOI: 10.3390/molecules23020444] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
9 Umemura H, Yamasaki O, Kaji T, Otsuka M, Asagoe K, Takata M, Iwatsuki K. Usefulness of serum 5-S-cysteinyl-dopa as a biomarker for predicting prognosis and detecting relapse in patients with advanced stage malignant melanoma. J Dermatol 2017;44:449-54. [PMID: 27786364 DOI: 10.1111/1346-8138.13651] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Belter B, Haase-kohn C, Pietzsch J; Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany, Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany, Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany, Department of Chemistry and Food Chemistry, Technische Universität Dresden, Dresden, Germany. Biomarkers in Malignant Melanoma: Recent Trends and Critical Perspective. In: Ward WH, Farma JM, editors. Cutaneous Melanoma: Etiology and Therapy. Codon Publications; 2017. pp. 39-56. [DOI: 10.15586/codon.cutaneousmelanoma.2017.ch3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
11 Pitcovski J, Shahar E, Aizenshtein E, Gorodetsky R. Melanoma antigens and related immunological markers. Critical Reviews in Oncology/Hematology 2017;115:36-49. [DOI: 10.1016/j.critrevonc.2017.05.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
12 Eisenstein A, Gonzalez EC, Raghunathan R, Xu X, Wu M, McLean EO, McGee J, Ryu B, Alani RM. Emerging Biomarkers in Cutaneous Melanoma. Mol Diagn Ther 2018;22:203-18. [PMID: 29411301 DOI: 10.1007/s40291-018-0318-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
13 Bidram M, Zhao Y, Shebardina NG, Baldin AV, Bazhin AV, Ganjalikhany MR, Zamyatnin AA Jr, Ganjalikhani-Hakemi M. mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients. Vaccines (Basel) 2021;9:1060. [PMID: 34696168 DOI: 10.3390/vaccines9101060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Sreejit G, Flynn MC, Patil M, Krishnamurthy P, Murphy AJ, Nagareddy PR. S100 family proteins in inflammation and beyond. Elsevier; 2020. pp. 173-231. [DOI: 10.1016/bs.acc.2020.02.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Alegre E, Zubiri L, Perez-Gracia JL, González-Cao M, Soria L, Martín-Algarra S, González A. Circulating melanoma exosomes as diagnostic and prognosis biomarkers. Clin Chim Acta 2016;454:28-32. [PMID: 26724367 DOI: 10.1016/j.cca.2015.12.031] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 11.4] [Reference Citation Analysis]
16 Hariri R, Saeedi M, Akbarzadeh T. Naturally occurring and synthetic peptides: Efficient tyrosinase inhibitors. J Pept Sci 2021;27:e3329. [PMID: 33860571 DOI: 10.1002/psc.3329] [Reference Citation Analysis]
17 Amalinei C, Grigoraș A, Lozneanu L, Căruntu I, Giușcă S, Balan RA. The Interplay between Tumour Microenvironment Components in Malignant Melanoma. Medicina 2022;58:365. [DOI: 10.3390/medicina58030365] [Reference Citation Analysis]
18 Alegre E, Sammamed M, Fernández-Landázuri S, Zubiri L, González Á. Circulating biomarkers in malignant melanoma. Adv Clin Chem 2015;69:47-89. [PMID: 25934359 DOI: 10.1016/bs.acc.2014.12.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
19 Karagiannis P, Villanova F, Josephs DH, Correa I, Van Hemelrijck M, Hobbs C, Saul L, Egbuniwe IU, Tosi I, Ilieva KM, Kent E, Calonje E, Harries M, Fentiman I, Taylor-Papadimitriou J, Burchell J, Spicer JF, Lacy KE, Nestle FO, Karagiannis SN. Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma. Oncoimmunology 2015;4:e1032492. [PMID: 26451312 DOI: 10.1080/2162402X.2015.1032492] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
20 Gao F, Sihver W, Bergmann R, Walther M, Stephan H, Belter B, Neuber C, Haase-Kohn C, Bolzati C, Pietzsch J, Pietzsch HJ. Radiochemical and radiopharmacological characterization of a 64 Cu-labeled α-MSH analog conjugated with different chelators. J Labelled Comp Radiopharm 2019;62:495-509. [PMID: 30912594 DOI: 10.1002/jlcr.3728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Shakya BR, Shrestha P, Teppo H, Rieppo L. The use of Fourier Transform Infrared (FTIR) spectroscopy in skin cancer research: a systematic review. Applied Spectroscopy Reviews 2021;56:347-79. [DOI: 10.1080/05704928.2020.1791152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Sousa A, Santos F, Gaspar MM, Calado S, Pereira JD, Mendes E, Francisco AP, Perry MJ. The selective cytotoxicity of new triazene compounds to human melanoma cells. Bioorganic & Medicinal Chemistry 2017;25:3900-10. [DOI: 10.1016/j.bmc.2017.04.049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
23 Kuchar M, Neuber C, Belter B, Bergmann R, Lenk J, Wodtke R, Kniess T, Steinbach J, Pietzsch J, Löser R. Evaluation of Fluorine-18-Labeled α1(I)-N-Telopeptide Analogs as Substrate-Based Radiotracers for PET Imaging of Melanoma-Associated Lysyl Oxidase. Front Chem 2018;6:121. [PMID: 29755969 DOI: 10.3389/fchem.2018.00121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
24 Aepler J, Wodtke J, Wodtke R, Haase-kohn C, Löser R, Pietzsch J, Hauser S. The Role of Transglutaminase 2 in the Radioresistance of Melanoma Cells. Cells 2022;11:1342. [DOI: 10.3390/cells11081342] [Reference Citation Analysis]
25 Naik PP. Role of Biomarkers in the Integrated Management of Melanoma. Dis Markers 2021;2021:6238317. [PMID: 35003391 DOI: 10.1155/2021/6238317] [Reference Citation Analysis]
26 Herwig N, Belter B, Pietzsch J. Extracellular S100A4 affects endothelial cell integrity and stimulates transmigration of A375 melanoma cells. Biochem Biophys Res Commun 2016;477:963-9. [PMID: 27387233 DOI: 10.1016/j.bbrc.2016.07.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
27 Kulbe JR, Geddes JW. Current status of fluid biomarkers in mild traumatic brain injury. Exp Neurol 2016;275 Pt 3:334-52. [PMID: 25981889 DOI: 10.1016/j.expneurol.2015.05.004] [Cited by in Crossref: 72] [Cited by in F6Publishing: 56] [Article Influence: 10.3] [Reference Citation Analysis]
28 Cherkouk C, Rebohle L, Lenk J, Keller A, Ou X, Laube M, Neuber C, Haase-kohn C, Skorupa W, Pietzsch J. Controlled immobilization of His-tagged proteins for protein-ligand interaction experiments using Ni2+-NTA layer on glass surfaces. CH 2016;61:523-39. [DOI: 10.3233/ch-151950] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Gassner C, Neuber C, Laube M, Bergmann R, Kniess T, Pietzsch J. Development of a 18 F-labeled Diaryl-Substituted Dihydropyrrolo[3,2,1- hi ]indole as Potential Probe for Functional Imaging of Cyclooxygenase-2 with PET. ChemistrySelect 2016;1:5812-20. [DOI: 10.1002/slct.201601618] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Wodtke R, Wodtke J, Hauser S, Laube M, Bauer D, Rothe R, Neuber C, Pietsch M, Kopka K, Pietzsch J, Löser R. Development of an 18F-Labeled Irreversible Inhibitor of Transglutaminase 2 as Radiometric Tool for Quantitative Expression Profiling in Cells and Tissues. J Med Chem 2021;64:3462-78. [PMID: 33705656 DOI: 10.1021/acs.jmedchem.1c00096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Laube M, Kniess T, Neuber C, Haase-Kohn C, Pietzsch J. Fluorine-18 Labeling of S100 Proteins for Small Animal Positron Emission Tomography. Methods Mol Biol 2019;1929:461-85. [PMID: 30710291 DOI: 10.1007/978-1-4939-9030-6_29] [Reference Citation Analysis]
32 Gao F, Sihver W, Jurischka C, Bergmann R, Haase-kohn C, Mosch B, Steinbach J, Carta D, Bolzati C, Calderan A, Pietzsch J, Pietzsch H. Radiopharmacological characterization of 64Cu-labeled α-MSH analogs for potential use in imaging of malignant melanoma. Amino Acids 2016;48:833-47. [DOI: 10.1007/s00726-015-2131-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
33 Falzone L, Romano GL, Salemi R, Bucolo C, Tomasello B, Lupo G, Anfuso CD, Spandidos DA, Libra M, Candido S. Prognostic significance of deregulated microRNAs in uveal melanomas. Mol Med Rep 2019;19:2599-610. [PMID: 30816460 DOI: 10.3892/mmr.2019.9949] [Cited by in Crossref: 34] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
34 Harris Z, Donovan MG, Branco GM, Limesand KH, Burd R. Quercetin as an Emerging Anti-Melanoma Agent: A Four-Focus Area Therapeutic Development Strategy. Front Nutr 2016;3:48. [PMID: 27843913 DOI: 10.3389/fnut.2016.00048] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
35 Vaníčková L, Do T, Vejvodová M, Horák V, Hubálek M, Emri G, Zemánková K, Pavelicová K, Křížková S, Faltusová V, Pompeiano A, Vaculovičová M, Zítka O, Vaculovič T, Adam V. Mapping of MeLiM melanoma combining ICP-MS and MALDI-MSI methods. Int J Biol Macromol 2022:S0141-8130(22)00154-4. [PMID: 35090942 DOI: 10.1016/j.ijbiomac.2022.01.139] [Reference Citation Analysis]
36 Almeida N, Rodriguez J, Pla Parada I, Perez-Riverol Y, Woldmar N, Kim Y, Oskolas H, Betancourt L, Valdés JG, Sahlin KB, Pizzatti L, Szasz AM, Kárpáti S, Appelqvist R, Malm J, B Domont G, C S Nogueira F, Marko-Varga G, Sanchez A. Mapping the Melanoma Plasma Proteome (MPP) Using Single-Shot Proteomics Interfaced with the WiMT Database. Cancers (Basel) 2021;13:6224. [PMID: 34944842 DOI: 10.3390/cancers13246224] [Reference Citation Analysis]